- BrandEnhertu
- Compositionfam-trastuzumab deruxtecan-nxki
- Strength100 mg
- Supply TypeExporter, Supplier, Distributor
- Preferred Buyer Location All over the world
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 gene mutations.